Mite allergen

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8647630
APP PUB NO 20120289679A1
SERIAL NO

13230448

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A safe and efficient recombinant mite allergen is provided as a therapeutic agent or a diagnostic agent for mite allergic diseases, which contains no anaphylaxis-inducing impurities. The following recombinant protein (a) or (b) is provided:

    (a) a protein comprising the amino acid sequence represented by SEQ ID NO: 2 or 35; or(b) a protein comprising an amino acid sequence derived from the amino acid sequence represented by SEQ ID NO: 2 or 35 by deletion, substitution, or addition of one or several amino acids and having mite allergen activity.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NIPPON ZENYAKU KOGYO CO LTDASAKA-MACHI KORIYAMA-SHI FUKUSHIMA 963-0196

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Iwabuchi, Shigehiro Fukushima, JP 7 12
Tsujimoto, Hajime Tokyo, JP 5 23
Tsukui, Toshihiro Fukushima, JP 10 15

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 11, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00